环球医疗器械 GMED
$71.05 −$10.39 (-12.76%)
休市 · Nov 7, 9:10 am ET · 最新盘后价 $71.20 +0.21%
开盘$74.10
昨收$81.44
当日区间$70.40 – $75.63
成交量9.27M
市值$9.41B
市盈率（TTM）17.5
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例91.7%+1.81 个百分点，较上季度
持仓机构数700+6 ，较上季度
内部人近期交易30次买入 / 19次卖出净买入
空头持仓比例6.10% 占流通股回补天数 5.5 · 截至 15 Oct 2026
卖空成交量占比21.3%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$9.73M（10个净流入日，10个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有38.8%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从5.07%升至6.10%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Swedbank Robur Fonder AB | Mutual Fund | 2026/Q3 | +2,360,480 | 2.1% |
| Kayne Anderson Rudnick Investment Management, LLC | Mutual Fund | 2026/Q3 | +4,279,730 | 3.2% |
| Boston Partners Global Investors, Inc. | Mutual Fund | 2026/Q3 | +1,554,990 | 1.2% |
| Allspring Global Investments, LLC | Mutual Fund | 2026/Q3 | +1,143,641 | 1.2% |
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q3 | +803,716 | 1.3% |
| Quantinno Capital Management LP | Mutual Fund | 2026/Q3 | +672,003 | 0.9% |
| Wells Fargo & Company | Public Company | 2026/Q3 | +668,668 | 0.7% |
| AllianceBernstein | Mutual Fund | 2026/Q3 | +629,512 | 1.8% |
| Goldman Sachs Asset Management, L.P. | Mutual Fund | 2026/Q3 | +614,919 | 1.0% |
| Invesco Ltd. | Mutual Fund | 2026/Q3 | +600,733 | 3.0% |
| Dimensional Fund Advisors | Mutual Fund | 2026/Q3 | +599,413 | 1.8% |
| Clark Capital Management Group Inc | Mutual Fund | 2026/Q3 | +586,212 | 0.5% |
| Janus Henderson Group plc | Mutual Fund | 2026/Q3 | +577,328 | 6.1% |
| Raymond James Financial, Inc. | Public Company | 2026/Q3 | +359,259 | 0.5% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +351,791 | 0.7% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 14 Sep 2026 | James Tobin | Independent Director | Derivative Exercise and Sale | -30,000 | $74.58 | – |
| 17 Aug 2026 | Stephen Zarrilli | Independent Director | Derivative Exercise and Sale | -25,000 | $87.04 | – |
| 26 Jul 2026 | David Davidar | Independent Director | Other Disposition | -2,500 | – | 673,642 |
| 4 Jun 2026 | David Davidar | Independent Director | Derivative Exercise and Sale | -25,000 | $80.76 | 676,142 |
| 3 Jun 2026 | Ann Rhoads | Independent Director | Derivative Exercise and Retained | +25,000 | $26.27 | 40,384 |
| 13 Apr 2026 | John DeFord | Former Independent Director | Intent to Sell (Form 144) | -30,000 | $93.10 | – |
| 24 Feb 2026 | Kelly Huller | General Counsel | Derivative Exercise and Sale | -20,000 | $94.50 | – |
| 11 Feb 2026 | Kelly Huller | General Counsel | Derivative Exercise and Sale | -10,000 | $87.67 | – |
| 20 Jan 2026 | Ann Rhoads | Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | John DeFord | Former Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | Stephen Zarrilli | Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | James Tobin | Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | David Paul | Co-Founder & Executive Chairperson | Other Derivative Acquisition | +100,000 | $94.15 | 100,000 |
| 20 Jan 2026 | Daniel Wolterman | Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | Robert Douglas | Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | David Davidar | Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | Leslie Norwalk | Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | Daniel Lemaitre | Independent Director | Other Derivative Acquisition | +15,000 | $94.15 | 15,000 |
| 20 Jan 2026 | Keith Pfeil | Chief Executive Officer | Other Derivative Acquisition | +100,000 | $94.15 | 100,000 |
| 20 Jan 2026 | Kelly Huller | General Counsel | Other Derivative Acquisition | +40,000 | $94.15 | 40,000 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 8,189,831 | 6.1% | 5.5 |
| 30 Sep 2026 | 8,437,114 | 6.3% | 5.1 |
| 15 Sep 2026 | 6,767,512 | 5.0% | 4.6 |
| 31 Aug 2026 | 6,620,718 | 4.9% | 6.5 |
| 14 Aug 2026 | 6,802,529 | 5.1% | 4.0 |
| 31 Jul 2026 | 6,886,644 | 5.1% | 4.9 |
暂无评论——快来第一个聊聊 GMED。
登录后参与讨论。